VRG50635

DRUG2 trials

Sponsors

Verge Genomics

Conditions

Amyotrophic Lateral SclerosisHealthy Volunteers

Phase 1

A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)

TerminatedNCT06215755

Verge GenomicsAmyotrophic Lateral Sclerosis

Start: 2024-01-15End: 2025-07-07Updated: 2025-12-15

A Study of VRG50635 in Healthy Volunteers

CompletedNCT06286475

Verge GenomicsHealthy Volunteers

Start: 2024-02-29End: 2024-04-08Updated: 2025-12-15